Order Detail

Order Acquisition of Business relating to a portfolio of Oncology products (excluding manufacturing) from Glaxosmithkline by Novaris A.G 09-02-2015
Brief Description
Section 11
Violation: Second Phase Review Order
Sector: Pharmaceutical
Penalty: No Penalty
Adjudicating Members
Mueen Batlay Member

© CCP 2024, Competition Commission of Pakistan ©All rights reserved